Session Details
[O41]一般演題(口演)41 先天異常・皮膚症候群②
Sat. Jun 7, 2025 9:15 AM - 10:05 AM JST
Sat. Jun 7, 2025 12:15 AM - 1:05 AM UTC
Sat. Jun 7, 2025 12:15 AM - 1:05 AM UTC
第7会場
座長:城所 博之(名古屋大学大学院医学系研究科小児科学),倉橋 宏和(愛知医科大学医学部小児科)
[O41-01]Effects of early everolimus treatment on the developing brain in tuberous sclerosis complex
○Naoko Ishihara, Gen Furukawa, Ayami Yoshikane, Shun Imamura, Yuri Kawai, Hidetoshi Uchida, Kazuyoshi Saito, Masafumi Miyata (Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan)
[O41-02]A case of neurofibromatosis type 1 who started taking selumetinib from early childhood
○Kotaro Kojima1, Kozue Mori1, Kenichi Maeda1, Noriko Hidaka1, Yasuhiro Kimoto1, Yukiyo Narita2, Masahiro Amano2, Hiroshi Moritake1 (1.Faculty of Medicine, University of Miyazaki, Miyazaki, Japan, 2.Faculty of Medicine, University of Miyazaki, Miyazaki, Japan)
[O41-03]Clinical profile of patients with tuberous sclerosis complex and medical cooperation in Gunma University Hospital
○Tomomi Ogata, Tokuyasu Arakawa, Minoru Shinagawa, Mari Hashimoto, Takumi Takizawa (Department of Pediatrics, Graduate School of Medicine, Gunma University, Maebashi, Japan)
[O41-04]Analysis of Tuberous Sclerosis Complex patients at Tottori university hospital
○Haruto Chishiro1, Yuko Nakamura2, Tohru Okanishi2, Yoshihiro Maegaki2 (1.School of Medicine,Ficulty of Medicine,Tottori University, Tottori,Japan, 2.Depertment of Childneurology,Tottori University,Tottori, Japan)
[O41-05]A 6-year-old girl with tuberous sclerosis whose epilepsy and TAND are being effectively treated with everolimus
○Genrei Ohta1,2,3, Yoshihiro Taniguchi1, Yumekichi Maeda2, Takuya Kosaka2,3, Masao Kawatani1,2,3 (1.Fukui Prefectural Hospital, 2.University of Fukui Hospital, 3.Fukui prefectural rehabilitation center for children with disabilities)